fluticasone and Pericardial-Effusion

fluticasone has been researched along with Pericardial-Effusion* in 1 studies

Other Studies

1 other study(ies) available for fluticasone and Pericardial-Effusion

Article	Year
BCNU toxicity presenting with a large pericardial and pleural effusion. Annals of transplantation, 2008, Volume: 13, Issue:1 Carmustine (BCNU), 1, 3-bis (2-chloroethyl)-1-nitosourea, is an alkylating agent which is commonly used as a part of conditioning regimen for autologous peripheral blood stem cell transplantation. Despite the widespread use of BCNU therapy in adults, cardiopulmonary toxicity presenting with cardiac tamponade has not been reported.. We present a patient who received BCNU as part of her conditioning regimen followed by autologous peripheral blood stem cell transplantation. This patient subsequently developed bilateral upper lobe pulmonary infiltrates with bilateral pleural effusions and a large pericardial effusion which was a result of BCNU toxicity.. Early institution of glucocorticoids for patients receiving high dose BCNU containing chemotherapeutic regimens has shown to significantly reduce BCNU induced cardio-pulmonary toxicity. Topics: Adult; Androstadienes; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Echocardiography; Female; Fluticasone; Humans; Lymphoma, T-Cell; Pericardial Effusion; Pleural Effusion; Stem Cell Transplantation; Tomography, X-Ray Computed	2008

Article

Year

BCNU toxicity presenting with a large pericardial and pleural effusion.

Annals of transplantation, 2008, Volume: 13, Issue:1

Carmustine (BCNU), 1, 3-bis (2-chloroethyl)-1-nitosourea, is an alkylating agent which is commonly used as a part of conditioning regimen for autologous peripheral blood stem cell transplantation. Despite the widespread use of BCNU therapy in adults, cardiopulmonary toxicity presenting with cardiac tamponade has not been reported.. We present a patient who received BCNU as part of her conditioning regimen followed by autologous peripheral blood stem cell transplantation. This patient subsequently developed bilateral upper lobe pulmonary infiltrates with bilateral pleural effusions and a large pericardial effusion which was a result of BCNU toxicity.. Early institution of glucocorticoids for patients receiving high dose BCNU containing chemotherapeutic regimens has shown to significantly reduce BCNU induced cardio-pulmonary toxicity.

Topics: Adult; Androstadienes; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Echocardiography; Female; Fluticasone; Humans; Lymphoma, T-Cell; Pericardial Effusion; Pleural Effusion; Stem Cell Transplantation; Tomography, X-Ray Computed

2008